Canada Generics Market Summary, Competitive Analysis and Forecast to 2027
Canada Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The Canadian generics market had total revenues of $6.2 billion in 2022, representing a compound annual growth rate (CAGR) of 4.5% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 1% between 2017 and 2022, to reach a total of 74.4 % in 2022.
- In 2022, the growth of the Canadian generics market decelerated, witnessing an annual growth of 3.2% due to the reduction in generic drug prices.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Canada
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Canada
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Canada generics market with five year forecasts by both value and volume
- What was the size of the Canada generics market by value in 2022?
- What will be the size of the Canada generics market in 2027?
- What factors are affecting the strength of competition in the Canada generics market?
- How has the market performed over the last five years?
- Who are the top competitors in Canada's generics market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Have there been any recent developments in the market?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Teva Pharmaceutical Industries Limited
8.3. Viatris Inc.
8.4. Apotex, Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Have there been any recent developments in the market?
8 COMPANY PROFILES
8.1. Novartis AG
8.2. Teva Pharmaceutical Industries Limited
8.3. Viatris Inc.
8.4. Apotex, Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Canada generics market value: $ million, 2017-22
Table 2: Canada generics market volume: %, 2017-22
Table 3: Canada generics market geography segmentation: $ million, 2022
Table 4: Canada generics market value forecast: $ million, 2022-27
Table 5: Canada generics market volume forecast: %, 2022-27
Table 6: Novartis AG: key facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Viatris Inc.: key facts
Table 14: Viatris Inc.: Annual Financial Ratios
Table 15: Viatris Inc.: Key Employees
Table 16: Viatris Inc.: Key Employees Continued
Table 17: Apotex, Inc.: key facts
Table 18: Apotex, Inc.: Key Employees
Table 19: Canada size of population (million), 2018-22
Table 20: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Canada gdp (current prices, $ billion), 2018-22
Table 22: Canada inflation, 2018-22
Table 23: Canada consumer price index (absolute), 2018-22
Table 24: Canada exchange rate, 2018-22
Table 1: Canada generics market value: $ million, 2017-22
Table 2: Canada generics market volume: %, 2017-22
Table 3: Canada generics market geography segmentation: $ million, 2022
Table 4: Canada generics market value forecast: $ million, 2022-27
Table 5: Canada generics market volume forecast: %, 2022-27
Table 6: Novartis AG: key facts
Table 7: Novartis AG: Annual Financial Ratios
Table 8: Novartis AG: Key Employees
Table 9: Novartis AG: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Viatris Inc.: key facts
Table 14: Viatris Inc.: Annual Financial Ratios
Table 15: Viatris Inc.: Key Employees
Table 16: Viatris Inc.: Key Employees Continued
Table 17: Apotex, Inc.: key facts
Table 18: Apotex, Inc.: Key Employees
Table 19: Canada size of population (million), 2018-22
Table 20: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 21: Canada gdp (current prices, $ billion), 2018-22
Table 22: Canada inflation, 2018-22
Table 23: Canada consumer price index (absolute), 2018-22
Table 24: Canada exchange rate, 2018-22
LIST OF FIGURES
Figure 1: Canada generics market value: $ million, 2017-22
Figure 2: Canada generics market volume: %, 2017-22
Figure 3: Canada generics market geography segmentation: % share, by value, 2022
Figure 4: Canada generics market value forecast: $ million, 2022-27
Figure 5: Canada generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in Canada, 2022
Figure 7: Drivers of buyer power in the generics market in Canada, 2022
Figure 8: Drivers of supplier power in the generics market in Canada, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Canada, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in Canada, 2022
Figure 11: Drivers of degree of rivalry in the generics market in Canada, 2022
Figure 1: Canada generics market value: $ million, 2017-22
Figure 2: Canada generics market volume: %, 2017-22
Figure 3: Canada generics market geography segmentation: % share, by value, 2022
Figure 4: Canada generics market value forecast: $ million, 2022-27
Figure 5: Canada generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in Canada, 2022
Figure 7: Drivers of buyer power in the generics market in Canada, 2022
Figure 8: Drivers of supplier power in the generics market in Canada, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Canada, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in Canada, 2022
Figure 11: Drivers of degree of rivalry in the generics market in Canada, 2022
